Abstract
This chapter investigates the impact of embryo research laws on the innovative ability of national economies. Based on a quantitative comparison of embryo research laws and biotechnology patents in 21 industrialised Western countries, this chapter makes three arguments. First, we observe a clear trend: Stem cell research has incited a wave of liberalizations of embryo research laws. Second, this trend is not universal. We notice a considerable variation in embryo research laws. This pattern can be explained by the interaction of partisan and societal actors. Third, the variation of embryo research laws is not directly related to the innovative ability of national economies. Permissive embryo research laws are not necessarily associated with an innovative biotechnology sector. The innovativeness often is an unintended consequence, rather than the result, of a political strategy. These results caution against simple theses about the impact of regulation on innovativeness. Impacts of embryo research laws on the innovative ability of the biotech sector will be visible only in the long-term.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arie, S. (2005). In Europe, Italy now a guardian of embryo rights. Christian Science Monitor, 14 June 2005.
Arundel, A. (2003). Biotechnology indicators and public policy. STI Working Papers, 2003(5).
Association of the British Pharmaceutical Industry (ABPI) (2004). Science and innovation: Working towards a ten-year investment framework. A response by the ABPI. http://www.abpi.org.uk/information/pdfs/S&I_consultation.doc. Accessed 20 April 2006.
Banchoff, T. (2005). Path dependence and value-driven issues: The comparative politics of stem cell research. World Politics, 57(2), 200–230.
Barr, T. (2003a). GE free NZ Inc. Submission on the supplementary order paper on the human assisted reproductive technology bill. http://www.biopolitics-berlin2003.org/doc_rt.asp?p=1&id=51. Accessed 28 February 2006.
Barr, T. (2003b). Made to order – the government buys into GE babies. OrganicNZ, 62(4), 20.
Bauer, M. W., & Gaskell, G. (Eds.). (2001). Biotechnology 1996–2000: The years of controversy. London: Science Museum.
Bauer, M. W., & Gaskell, G. (Eds.). (2002). Biotechnology: The making of a global controversy. Cambridge: Cambridge University Press.
Blair, T. (2000a). Biotechnology: Investing in the future. Speech held on 17 November 2000, London, http://webarchive.nationalarchives.gov.uk/20060715135117/number10.gov.uk/page1548.
Blair, T. (2000b). Wir werden Europa führen. Frankfurter Allgemeine Zeitung, 8 December 2000.
Bondevik, K. M. (2003). Speech at Trans-Atlantic Dialogue on GenEthics and Health. Centre for Strategic & International Studies, Washington, DC.
Broughton, D. (1988). The social bases of Western European conservative parties. In B. Girvin (Ed.), The transformation of contemporary conservatism (pp. 193–224). London: Sage.
Burgermeister, J. (2003). Danes begin stem cell work. The Scientist Daily News, 28 October 2003.
Burrell, R. (2005). Assisted reproduction in the Nordic countries: A comparative study of policies and regulation. Nordic Committee on Bioethics.
Campbell, C. S. (2001). Source or resource? Human embryo research as an ethical issue. In P. Lauritzen (Ed.), Cloning and the future of human embryo research (pp. 34–49). Oxford: Oxford University Press.
Castles, F. G. (1994). On religion and public policy: Does Catholicism make a difference? European Journal of Political Research, 25(1), 19–40.
European Commission. (2005). European research projects involving stem cells in the 6th Framework Programme. Brussels: European Commission.
Council of Europe. (1998). Medically assisted procreation and the protection of the human embryo: Comparative study on the situation in 39 states. Strasbourg: Council of Europe.
Deutsche Forschungsgemeinschaft (2001). Stellungnahme zur Forschung mit embryonalen Stammzellen.
Dodson, L., & Gray, D. (2002). Embryo ban hits research. http://www.theage.com.au/articles/2002/02/25/1014471629519.html.
Duverger, M. (1966). Sociologie politique. Paris: PUF.
Fink, S. (2007a). Ein deutscher Sonderweg? Die deutsche Embryonenforschungspolitik im Licht international vergleichender Daten. Leviathan, 1(2007), 107–128.
Fink, S. (2007b). Ethics vs. innovation? The impact of embryo research laws on the innovative ability of national economies. Science, Technology & Innovation Studies, 3(2), 133–149.
Fink, S. (2008a). Forschungspolitik zwischen Innovation und Lebensschutz. Die Determinanten von Embryonenforschungspolitiken im internationalen Vergleich (Staatslehre und politische Verwaltung). Baden-Baden: Nomos.
Fink, S. (2008b). Politics as usual or bringing religion back in? The influence of parties, institutions, economic interests and religion on embryo research laws. Comparative Political Studies, 41(12), 1631–1656.
Fink, S. (2009). Churches as societal veto players: Religious influence in actor-centered theories of policy making. West European Politics, 32(1), 77–96.
Futurewatch. (2006). Stem cell research in New Zealand. Wellington: Ministry of Research, Science and Technology.
Gearhart, J. (1998). New potential for human embryonic stem cells. Science, 282(5391), 1061–1062.
Gottweis, H. (1998). Governing molecules: The discursive politics of genetic engineering in Europe and the United States. Cambridge, MA: MIT Press.
Grabner, P. (1999). Technik, Politik und Gesellschaft: Eine Untersuchung am Beispiel des österreichischen Gentechnikgesetzes. Wien: Peter Lang.
Gratton, B. (2002). Survey on the national regulations in the European Union regarding research on human embryos. Report for The European Group on Ethics in Science and New Technologies (EGE).
Hadolt, B. (2005). Reproduktionstechnologiepolitik in Österreich: Die Genese des Fortpflanzungsmedizingesetzes 1992 und die Rolle von ExpertInnen. Reihe Soziologie: Institut für höhere Studien Wien. 74.
Hague, A. (2006). Stem cell research in Sweden: An overview. Stockholm: British Embassy.
Haines, L. (2005). Spain greenlights therapeutic cloning. The Register, 11 July 2005.
Hanley, D. (1994). Introduction. Christian Democracy as a political phenomenon. In D. Hanley (Ed.), Christian democracy in Europe: A comparative perspective. London: Pinter.
Kallerud, E. (2004). The ambiguity of progress: Biotechnology in Norway. In M. Häyrinen-Alestalo, & E. Kallerud (Eds.), Mediating public concern in biotechnology a map of sites, actors and issues in Denmark, Finland, Norway and Sweden. Norwegian Institute for Studies in Research and Higher Education Rapport 2/2004 (pp. 83–112).
Körtner, U. (2002). Ethische Fragen der Biotechnologie. In C. Kopetzki, & H. Mayer (Eds.), Biotechnologie und Recht (pp. 1–14). Wien: Manz´sche Verlags- und Universitätsbuchhandlung.
Kulawik, T. (2003). Gender representation and the politics of biotechnology in Sweden: Explaining liberal regulations in a social democratic state. Paper presented at the The ECPR General Conference, Marburg, September 19–21
Lauritzen, P. (Ed.). (2001). Cloning and the future of human embryo research. Oxford: Oxford University Press.
Lilge, W. (2001). The case for adult stem cell research. 21st Century Science and Technology Magazine, Winter 2001–2002.
Lorenzi, R. (2003). Italy approves embryo law. The Scientist Daily News. 12 December 2003.
Mayntz, R., & Nedelmann, B. (1987). Eigendynamische soziale Prozesse: Anmerkungen zu einem analytischen Paradigma. Kölner Zeitschrift für Soziologie und Sozialpsychologie, 4(39), 648–669.
Mendieta, E. (2004). Habermas on human cloning. Philosophy and Social Criticism, 30(5–6), 721–743.
Minkenberg, M. (2002). Religion and public policy: Institutional, cultural, and political impact on the shaping of abortion policies in Western Democracies. Comparative Political Studies, 35(2), 221–247.
Mulkay, M. (1997). The embryo research debates: Science and the politics of reproduction. Cambridge: Cambridge University Press.
Packer, K., & Webster, A. (1996). Patenting culture in science: Reinventing the scientific wheel of credibility. Science, Technology & Human Values, 21(4), 427–453.
Pierson, P. (2000). Increasing returns, path dependence, and the study of politics. American Political Science Review, 94(2), 251–267.
Pierson, P. (2004). Politics in time: History, institutions, and social analysis. Princeton: Princeton University Press.
Ramjoué, C., & Klöti, U. (2004). ART policy in Italy: Explaining the lack of comprehensive regulation. In I. Bleiklie, M. L. Goggin, & C. Rothmayr (Eds.), Comparative biomedical policy: Governing assisted reproductive technologies (pp. 42–63). London: Routledge.
Rothmayr, C., & Ramjoué, C. (2004). Germany. ART policies as embryo protection. In I. Bleiklie, M. L. Goggin, & C. Rothmayr (Eds.), Comparative biomedical policy: Governing assisted reproductive technologies (pp. 174–190). London: Routledge.
Ryan, M. A. (2001). Creating embryos for research: On weighing symbolic costs. In P. Lauritzen (Ed.), Cloning and the future of human embryo research (pp. 50–66). Oxford: Oxford University Press.
Scharpf, F. W. (1997). Games real actors play: Actor-centered institutionalism in policy research. Boulder: Westview Press.
Schiffino, N., & Varone, F. (2004). ART policy in Belgium: A bioethical paradise? In I. Bleiklie, M. L. Goggin, & C. Rothmayr (Eds.), Comparative biomedical policy: Governing assisted reproductive technologies (pp. 21–41). London: Routledge.
Schmidt, M. G. (1993). Theorien in der international vergleichenden Staatstätigkeitsforschung. In A. Héritier (Ed.), Policy-Analyse. Kritik und Neuorientierung (pp. 371–393). Opladen: Westdeutscher Verlag.
Schneider, V., & Bauer, J. (2007). Governance: Prospects of complexity theory in revisiting system theory. Quello Center Working Papers, 07–01. East Lansing, MI: Michigan State University.
Simons, M. (2004). Church and state clash, noisily, in Spain. NYTimes on the Web, 4 October 2004.
Sleator, A. (2000). Stem cell research under the Human Fertilisation and Embryology Act 1990. House of Commons Library Research Paper 00/93. London.
Spaemann, R. (2001). Gezeugt, nicht gemacht. Die verbrauchende Embryonenforschung ist ein Anschlag auf die Menschenwürde. In C. Geyer (Ed.), Biopolitik (pp. 41–50). Frankfurt/M: Suhrkamp.
Spar, D. (2004). The business of stem cells. New England Journal of Medicine, 351, 211–213.
Standing Committee on Legal and Constitutional Affairs (2000). Scientific, ethical and regulatory aspects of human cloning and stem cell research. Public hearing. House of Representatives, Parliament of Australia.
Standing Committee on Legal and Constitutional Affairs. (2001). Scientific, ethical and regulatory aspects of human cloning and stem cell research. Parliament of Australia: House of Representatives.
Steinbock, B. (2001). Respect for human embryos. In P. Lauritzen (Ed.), Cloning and the future of human embryo research (pp. 21–33). Oxford: Oxford University Press.
Stock, G., & Campbell, J. (Eds.). (2000). Engineering the human germline: An exploration of the science and ethics of altering the genes we pass on to our children. Oxford: Oxford University Press.
Stranzinger, P. (1992). Die artifizielle menschliche Fortpflanzung aus medizinischer, ethischer und juristischer Sicht: Staatliche und kirchliche Standpunkte zur artifiziellen Insemination, zur In-vitro-Fertilisation und zum Umgang mit menschlichen Embryonen - ein Vergleich. Salzburg, Salzburg: Univ.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
Torgersen, H., Hampel, J., Jelsøe, E., et al. (2002). Promise, problems and proxies: Twenty-five years of debate and regulation in Europe. In M. W. Bauer & G. Gaskell (Eds.), Biotechnology: The making of a global controversy (pp. 21–94). Cambridge: Cambridge University Press.
UNESCO. (2004). National legislation concerning human reproductive and therapeutic cloning. Paris: UNESCO.
Van Beuzekom, B. (2001). Biotechnology statistics in OECD member countries: Compendium of existing national statistics. STI Working Papers, 2001(6).
Varone, F., & Schiffino, N. (2004). Regulating red and green biotechnologies in Belgium: Diverging designs of biopolicies. Archives of Public Health, 62(1–2), 83–106.
Varone, F., & Schiffino, N. (2007). Conflict and consensus in Belgian biopolicies: GMO controversy versus biomedical self-regulation. In É. Montpetit, C. Rothmayr, & F. Varone (Eds.), The politics of biotechnology in North America and Europe: Policy networks, institutions, and internationalization (pp. 193–213). Lanham, MD: Lexington Books.
Vatican Congregation for the Doctrine of Faith. (1987). Donum vitae: Instruction on respect for human life in its origin and on the dignity of the procreation. Origins, 40, 697–711.
Walters, L. (2004). Human embyronic stem cell research: An intercultural perspective. Kennedy Institute of Ethics Journal, 14(1), 3–38.
Warren, J., & Osborne, R. (2006). Attitudes to embryonic stem cell research in New Zealand. Wellington: Bioethics Council of New Zealand.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fink, S. (2012). A Paradigm Change in Innovation Policies? Assessing the Causes and Consequences of Embryo Research Laws. In: Bauer, J., Lang, A., Schneider, V. (eds) Innovation Policy and Governance in High-Tech Industries. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-12563-8_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-12563-8_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12562-1
Online ISBN: 978-3-642-12563-8
eBook Packages: Business and EconomicsEconomics and Finance (R0)